Literature DB >> 24376189

Infectivity of urogenital Chlamydia trachomatis plasmid-deficient, CT135-null, and double-deficient strains in female mice.

Gail L Sturdevant1, Bing Zhou, John H Carlson, William M Whitmire, Lihua Song, Harlan D Caldwell.   

Abstract

Chlamydia trachomatis is the most common cause of human bacterial sexually transmitted infections and is the world's leading cause of infectious preventable blindness. The chlamydial 7.5-kb plasmid and chromosomal gene CT135 have been shown to be important virulence factors in both nonhuman primate and mouse infection models. Chlamydia trachomatis plasmid-deficient urogenital isolates and a predicted CT135 null mutant have been evaluated independently in the female mouse genital tract model and both have been shown to reduce infectivity and virulence. However, these attenuating phenotypes have not been evaluated collectively in the murine model. Here, we test the infectivity of C. trachomatis serovar D strains in the mouse model that are plasmid-deficient, CT135 disrupted, or possess a combination of these attenuating genotypes. We find that the presence of the plasmid results in infections with higher infectious burdens, whereas CT135 facilitates a more protracted or chronic infection. Not unexpectedly, a combination of these genetic deficiencies resulted in a strain with enhanced infection attenuation characteristics.
© 2013 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  CT135; Chlamydiae; mouse infectivity; plasmid

Mesh:

Substances:

Year:  2014        PMID: 24376189      PMCID: PMC4048644          DOI: 10.1111/2049-632X.12121

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  19 in total

1.  A plasmid-cured Chlamydia muridarum strain displays altered plaque morphology and reduced infectivity in cell culture.

Authors:  Catherine M O'Connell; Kristy M Nicks
Journal:  Microbiology       Date:  2006-06       Impact factor: 2.777

Review 2.  Chlamydial infections (first of three parts).

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1978-02-23       Impact factor: 91.245

Review 3.  The relation of the psittacosis group (Chlamydiae) to bacteria and viruses.

Authors:  J W Moulder
Journal:  Annu Rev Microbiol       Date:  1966       Impact factor: 15.500

4.  A common plasmid of Chlamydia trachomatis.

Authors:  L Palmer; S Falkow
Journal:  Plasmid       Date:  1986-07       Impact factor: 3.466

Review 5.  Corneal blindness: a global perspective.

Authors:  J P Whitcher; M Srinivasan; M P Upadhyay
Journal:  Bull World Health Organ       Date:  2003-07-07       Impact factor: 9.408

6.  The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor.

Authors:  John H Carlson; William M Whitmire; Deborah D Crane; Luke Wicke; Kimmo Virtaneva; Daniel E Sturdevant; John J Kupko; Stephen F Porcella; Neysha Martinez-Orengo; Robert A Heinzen; Laszlo Kari; Harlan D Caldwell
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

Review 7.  Vaccines for Chlamydia infections of the female genital tract.

Authors:  Louise M Hafner; Celia McNeilly
Journal:  Future Microbiol       Date:  2008-02       Impact factor: 3.165

8.  Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis.

Authors:  R S Stephens; S Kalman; C Lammel; J Fan; R Marathe; L Aravind; W Mitchell; L Olinger; R L Tatusov; Q Zhao; E V Koonin; R W Davis
Journal:  Science       Date:  1998-10-23       Impact factor: 47.728

9.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

10.  Plasmid deficiency in urogenital isolates of Chlamydia trachomatis reduces infectivity and virulence in a mouse model.

Authors:  Ira M Sigar; Justin H Schripsema; Yibing Wang; Ian N Clarke; Lesley T Cutcliffe; Helena M B Seth-Smith; Nicholas R Thomson; Carina Bjartling; Magnus Unemo; Kenneth Persson; Kyle H Ramsey
Journal:  Pathog Dis       Date:  2013-09-10       Impact factor: 3.166

View more
  6 in total

Review 1.  Update on Chlamydia trachomatis Vaccinology.

Authors:  Luis M de la Maza; Guangming Zhong; Robert C Brunham
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

2.  The Chlamydia trachomatis Inclusion Membrane Protein CTL0390 Mediates Host Cell Exit via Lysis through STING Activation.

Authors:  R Clayton Bishop; Isabelle Derré
Journal:  Infect Immun       Date:  2022-05-19       Impact factor: 3.609

3.  Benzylidene acylhydrazides inhibit chlamydial growth in a type III secretion- and iron chelation-independent manner.

Authors:  Xiaofeng Bao; Asa Gylfe; Gail L Sturdevant; Zheng Gong; Shuang Xu; Harlan D Caldwell; Mikael Elofsson; Huizhou Fan
Journal:  J Bacteriol       Date:  2014-06-09       Impact factor: 3.490

4.  Chlamydia trachomatis In Vivo to In Vitro Transition Reveals Mechanisms of Phase Variation and Down-Regulation of Virulence Factors.

Authors:  Vítor Borges; Miguel Pinheiro; Minia Antelo; Daniel A Sampaio; Luís Vieira; Rita Ferreira; Alexandra Nunes; Filipe Almeida; Luís J Mota; Maria J Borrego; João P Gomes
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

5.  The Chlamydia trachomatis Plasmid and CT135 Virulence Factors Are Not Essential for Genital Tract Infection or Pathology in Female Pig-Tailed Macaques.

Authors:  Dorothy L Patton; Harlan D Caldwell; Yvonne C Sweeney; Audrey E Baldessari; Linda Cles; Laszlo Kari; Gail L Sturdevant; Chunfu Yang
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

6.  Early microRNA expression profile as a prognostic biomarker for the development of pelvic inflammatory disease in a mouse model of chlamydial genital infection.

Authors:  Laxmi Yeruva; Garry S A Myers; Nicole Spencer; Heather Huot Creasy; Nancy E Adams; Anthony T Maurelli; Grant R McChesney; Mario A Cleves; Jacques Ravel; Anne Bowlin; Roger G Rank
Journal:  mBio       Date:  2014-06-24       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.